TYRA-430 is an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers. The US Food and Drug Administration has cleared Tyra's Investigational New Drug application to ...
At a recent event organized by the Indian Council of Medical Research (ICMR), Dr Nehal Shah, a physiotherapist from BMHRC, won the Best Poster Award for her project on combating anemia in rural ...
Verrica Pharmaceuticals (VRCA) announced the presentation of three posters that were presented at the 2025 Winter Clinical Dermatology Conference, which was held from January 17-19, in Miami ...
Trained immunity, a modification of cells in the innate immune system, may represent a new way of protecting poultry from infectious diseases. In a recent review article, researchers from Japan ...